Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory to Standard Therapies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07729826
What this trial is testing

C-CAR168 CAR T-Cell Therapy for the Treatment of Lupus Nephritis Refractory to Standard Therapy

Who this might be right for
Lupus Nephritis (LN)Systemic Lupus Erythematosus (SLE)Autoimmune Diseases
AbelZeta Inc. 50
Testing effectiveness (Phase 2)Ended earlyNCT02401542
What this trial is testing

Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma

Who this might be right for
Locally Advanced or Metastatic Urothelial Cell CarcinomaUrinary Bladder DiseaseUrological Diseases
Rainier Therapeutics 71
Early research (Phase 1)Looking for participantsNCT05137054
What this trial is testing

Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

Who this might be right for
Multiple Myeloma
Regeneron Pharmaceuticals 317
Large-scale testing (Phase 3)WithdrawnNCT04572776
What this trial is testing

Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain

Who this might be right for
Pain, IntractablePain Cancer
Sorrento Therapeutics, Inc.
Early research (Phase 1)Looking for participantsNCT07688187
What this trial is testing

Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
PeptiDream Inc. 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748689
What this trial is testing

Comparing Lower Versus Standard Doses of Belantamab Mafodotin With Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma.

Who this might be right for
Relapsed / Refractory Multiple Myeloma
Polish Myeloma Consortium 228
Testing effectiveness (Phase 2)WithdrawnNCT05295589
What this trial is testing

Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy

Who this might be right for
Platinum-Refractory Fallopian Tube CarcinomaPlatinum-Refractory Ovarian CarcinomaPlatinum-Refractory Primary Peritoneal Carcinoma+9 more
National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT00121745
What this trial is testing

Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Epeius Biotechnologies 12
Early research (Phase 1)Active Not RecruitingNCT02112565
What this trial is testing

RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
City of Hope Medical Center 12
Early research (Phase 1)Study completedNCT02085148
What this trial is testing

A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy

Who this might be right for
Pediatric Oncology
Bayer 62
Testing effectiveness (Phase 2)Looking for participantsNCT07096934
What this trial is testing

Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care

Who this might be right for
Diabetic Foot Ulcer (DFU)
FibroBiologics 120
Not applicableNo Longer AvailableNCT02973620
What this trial is testing

Levosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart Failure

Who this might be right for
Heart Decompensation
Tenax Therapeutics, Inc.
Early research (Phase 1)Study completedNCT00878423
What this trial is testing

Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors

Who this might be right for
Metastatic Solid Tumors
Astex Pharmaceuticals, Inc. 62
Not applicableLooking for participantsNCT07398599
What this trial is testing

Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study

Who this might be right for
Leptomeningeal MetastasisLung Neoplasms, Non-Small Cell Lung Cancer
Second Affiliated Hospital of Nanchang University 30
Early research (Phase 1)Study completedNCT02690337
What this trial is testing

Study of DS-1123a in Advanced Solid Tumours

Who this might be right for
Advanced Solid Malignant Tumors
Daiichi Sankyo Co., Ltd. 27
Early research (Phase 1)Study completedNCT01924689
What this trial is testing

Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies

Who this might be right for
Solid Tumor Malignancies
BioMed Valley Discoveries, Inc 24
Early research (Phase 1)Ended earlyNCT02508441
What this trial is testing

Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors

Who this might be right for
Advanced Unresectable Solid Tumors
Andes Biotechnologies 22
Testing effectiveness (Phase 2)Study completedNCT00350753
What this trial is testing

Avastin and Tarceva for Upper Gastrointestinal Cancers

Who this might be right for
CholangiocarcinomaGallbladder Cancer
Rigshospitalet, Denmark 126
Early research (Phase 1)Study completedNCT01209143
What this trial is testing

Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists

Who this might be right for
Solid Cancers
Genentech, Inc. 52
Early research (Phase 1)Study completedNCT00816361
What this trial is testing

A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573 in Subjects With Advanced Solid Tumors

Who this might be right for
Cancer
MedImmune LLC 43
Next Page